Mengjie Yu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mengjie Yu has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
- Shouhua Zhang
Department of General Surgery, Jiangxi Provincial Children's Hospital, Nanchang, Jiangxi, China
3 shared publications Dan Nie
Department of General Surgery The Affiliated Children's Hospital of Nanchang Medical College Nanchang Jiangxi China
2 shared publicationsLeifeng Chen
Department of General Surgery Second Affiliated Hospital of Nanchang University Nanchang Jiangxi China
2 shared publicationsDanxia Zhu
Department of Oncology The Third Affiliated Hospital of Soochow University Changzhou PR China
1 shared publicationDeng Xiang
Jiangxi Prov Childrens Hosp, Dept Gen Surg, 122 Yangming Rd, Nanchang 330006, Jiangxi, Peoples R China
1 shared publicationDou Yang
State Key Laboratory of Natural Medicines China Pharmaceutical University Nanjing PR China
1 shared publication
Latest Publications
- 29 May 2026
- Published by Springer Nature in Acta Pharmacologica Sinica
- Vol. 47 (9) , 1-17
Activation of peripheral muscarinic receptors rescues depressive-like behaviors via gut-brain-axis, involving parasympathetic excitation
Dysfunction of the autonomic nervous system (ANS) is strongly linked to the pathophysiological mechanisms of depression. Unfortunately, the correlation between depressive-like behaviors and the activation or inhibition of the sympathetic/parasympathetic nervous system has not been systematically explored. This study demonstrated that the pharmacological activation of sympathetic α-/β-adrenergic receptors increased stress susceptibility, whereas their antagonists enhanced stress resistance, thus suggesting a close correlation between sympathetic activity and depressive-like behaviors. Furthermore, arecoline, an agonist of the peripheral parasympathetic muscarinic (M) receptors, has exhibited significant antidepressant effects in multiple murine depression models, and its antidepressant effects could be blocked by the M receptor antagonist known as atropine, thus indicating that parasympathetic excitability regulates depressive-like behaviors. Moreover, arecoline acted on peripheral M receptors to activate glutamatergic neurons in the anterior cingulate cortex (ACCGlu) via the vagus nerve and nucleus tractus solitarius (NTS) in sequence. Chemogenetic manipulation confirmed that the antidepressant effect of arecoline is dependent on the activation of ACCGlu neurons, and direct activation of these ACCGlu neurons exerts an antidepressant effect. Notably, pharmacological activation of peripheral parasympathetic M receptors can regulate the activation of the nodose ganglion (NG)–NTS–ACCGlu neural axis and modulate depressive-like behaviors. For the first time, this study indicates that peripheral M receptors are promising targets for antidepressants development and proposes a potential antidepressant strategy involving the pharmacological modulation of peripheral autonomic balance.
- 29 May 2026
- Published by Springer Nature in Acta Pharmacologica Sinica
- Vol. 47 (9) , 1-17
Activation of peripheral muscarinic receptors rescues depressive-like behaviors via gut-brain-axis, involving parasympathetic excitation
Dysfunction of the autonomic nervous system (ANS) is strongly linked to the pathophysiological mechanisms of depression. Unfortunately, the correlation between depressive-like behaviors and the activation or inhibition of the sympathetic/parasympathetic nervous system has not been systematically explored. This study demonstrated that the pharmacological activation of sympathetic α-/β-adrenergic receptors increased stress susceptibility, whereas their antagonists enhanced stress resistance, thus suggesting a close correlation between sympathetic activity and depressive-like behaviors. Furthermore, arecoline, an agonist of the peripheral parasympathetic muscarinic (M) receptors, has exhibited significant antidepressant effects in multiple murine depression models, and its antidepressant effects could be blocked by the M receptor antagonist known as atropine, thus indicating that parasympathetic excitability regulates depressive-like behaviors. Moreover, arecoline acted on peripheral M receptors to activate glutamatergic neurons in the anterior cingulate cortex (ACCGlu) via the vagus nerve and nucleus tractus solitarius (NTS) in sequence. Chemogenetic manipulation confirmed that the antidepressant effect of arecoline is dependent on the activation of ACCGlu neurons, and direct activation of these ACCGlu neurons exerts an antidepressant effect. Notably, pharmacological activation of peripheral parasympathetic M receptors can regulate the activation of the nodose ganglion (NG)–NTS–ACCGlu neural axis and modulate depressive-like behaviors. For the first time, this study indicates that peripheral M receptors are promising targets for antidepressants development and proposes a potential antidepressant strategy involving the pharmacological modulation of peripheral autonomic balance.
- Open Access
- 5 November 2025
- Published by BMJ in World Journal of Pediatric Surgery
- Vol. 8 (5) , e001079
Application of artificial intelligence in conjunction with clinical laboratory indicators to aid decision-making for surgical or conservative treatment of pediatric intestinal obstruction
Background: Management of pediatric intestinal obstruction remains clinically challenging, particularly regarding the selection between surgical and conservative approaches. This study aimed to develop artificial intelligence (AI) models to support treatment decision-making. Methods: A retrospective analysis was conducted on clinical data from pediatric intestinal obstruction patients. The dataset was split via stratified sampling (70% training/ 30% test), preserving outcome distribution. Predictive models incorporating clinical indicators were developed using machine learning, with evaluation metrics including accuracy, F1-score, Kappa value, positive predictive value (PPV), negative predictive value (NPV), precision-recall curves, calibration plots and decision curve analysis (DCA). Results: Among 765 pediatric patients, 425 responded to conservative treatment while 340 required surgery. The Random Forest model demonstrated optimal performance in the test cohort (area under the curve: 0.953; sensitivity: 0.879; specificity: 0.901; accuracy: 0.892; F1-score: 0.878; Kappa value: 0.780; PPV: 0.878; NPV: 0.905). Calibration, precision-recall, and DCAs indicated favorable clinical applicability. Conclusion: Machine learning integration with clinical indicators shows potential as a decision-support tool for selecting surgical or conservative treatment in pediatric intestinal obstruction.
- 5 November 2025
- Published by BMJ in World Journal of Pediatric Surgery
- Vol. 8 (5) , e001079
Open AccessApplication of artificial intelligence in conjunction with clinical laboratory indicators to aid decision-making for surgical or conservative treatment of pediatric intestinal obstruction
Background: Management of pediatric intestinal obstruction remains clinically challenging, particularly regarding the selection between surgical and conservative approaches. This study aimed to develop artificial intelligence (AI) models to support treatment decision-making. Methods: A retrospective analysis was conducted on clinical data from pediatric intestinal obstruction patients. The dataset was split via stratified sampling (70% training/ 30% test), preserving outcome distribution. Predictive models incorporating clinical indicators were developed using machine learning, with evaluation metrics including accuracy, F1-score, Kappa value, positive predictive value (PPV), negative predictive value (NPV), precision-recall curves, calibration plots and decision curve analysis (DCA). Results: Among 765 pediatric patients, 425 responded to conservative treatment while 340 required surgery. The Random Forest model demonstrated optimal performance in the test cohort (area under the curve: 0.953; sensitivity: 0.879; specificity: 0.901; accuracy: 0.892; F1-score: 0.878; Kappa value: 0.780; PPV: 0.878; NPV: 0.905). Calibration, precision-recall, and DCAs indicated favorable clinical applicability. Conclusion: Machine learning integration with clinical indicators shows potential as a decision-support tool for selecting surgical or conservative treatment in pediatric intestinal obstruction.
- 20 June 2025
- Published by Wiley in The Journal of Pathology
- Vol. 266 (4-5) , 465-480
Circulating metabolomics reveals guanosine monophosphate synthetase (GMPS) as a novel therapeutic target in lung adenocarcinoma
Metabolic reprogramming is pivotal in the initiation and progression of lung adenocarcinoma (LUAD). However, a substantial gap remains in the understanding of the primary drivers of metabolic reprogramming and alterations in early‐stage LUAD. Using an unbiased, large‐scale metabolomics analysis of 2,531 plasma and serum samples from three independent clinical centers, we identified significant perturbations in purine metabolism that characterized reprogrammed metabolism in early‐stage LUAD. Additionally, hypoxanthine (p < 0.001) and xanthine (p < 0.05) were identified as two typical early risk indicators, with odd ratios (ORs) more than 2.8 and 1.45, respectively. Guanosine monophosphate synthetase (GMPS) was identified as a pivotal factor in the early development and malignant progression of LUAD. Progression of LUAD was significantly attenuated by GMPS knockdown and markedly exacerbated by its overexpression. Further data indicated that GMPS primarily contributed to the reprogrammed metabolic phenotypes of LUAD through its enzymatic activity and subsequent production of purine nucleotides, based on the relative abundance of the labeled isotope metabolites. Collectively, dysregulated purine metabolism emerged as a key characteristic of early‐stage LUAD, and targeting GMPS activity may offer a promising therapeutic potential for LUAD treatment. © 2025 The Pathological Society of Great Britain and Ireland.
- 20 June 2025
- Published by Wiley in The Journal of Pathology
- Vol. 266 (4-5) , 465-480
Circulating metabolomics reveals guanosine monophosphate synthetase (GMPS) as a novel therapeutic target in lung adenocarcinoma
Metabolic reprogramming is pivotal in the initiation and progression of lung adenocarcinoma (LUAD). However, a substantial gap remains in the understanding of the primary drivers of metabolic reprogramming and alterations in early‐stage LUAD. Using an unbiased, large‐scale metabolomics analysis of 2,531 plasma and serum samples from three independent clinical centers, we identified significant perturbations in purine metabolism that characterized reprogrammed metabolism in early‐stage LUAD. Additionally, hypoxanthine (p < 0.001) and xanthine (p < 0.05) were identified as two typical early risk indicators, with odd ratios (ORs) more than 2.8 and 1.45, respectively. Guanosine monophosphate synthetase (GMPS) was identified as a pivotal factor in the early development and malignant progression of LUAD. Progression of LUAD was significantly attenuated by GMPS knockdown and markedly exacerbated by its overexpression. Further data indicated that GMPS primarily contributed to the reprogrammed metabolic phenotypes of LUAD through its enzymatic activity and subsequent production of purine nucleotides, based on the relative abundance of the labeled isotope metabolites. Collectively, dysregulated purine metabolism emerged as a key characteristic of early‐stage LUAD, and targeting GMPS activity may offer a promising therapeutic potential for LUAD treatment. © 2025 The Pathological Society of Great Britain and Ireland.
- 31 October 2023
- Published by Wiley in International Journal of Rheumatic Diseases
- Vol. 26 (12) , 2534-2542
Artificial intelligence differentiates abdominal Henoch‐Schönlein purpura from acute appendicitis in children
Objective: This study aims to construct an artificial intelligence (AI) model capable of effectively discriminating between abdominal Henoch‐Schönlein purpura (AHSP) and acute appendicitis (AA) in pediatric patients.Methods: A total of 6965 participants, comprising 2201 individuals with AHSP and 4764 patients with AA, were enrolled in the study. Additionally, 53 laboratory indicators were taken into consideration. Five distinct artificial intelligence (AI) models were developed employing machine learning algorithms, namely XGBoost, AdaBoost, Gaussian Naïve Bayes (GNB), MLPClassifier (MLP), and support vector machine (SVM). The performance of these prediction models was assessed through receiver operating characteristic (ROC) curve analysis, calibration curve assessment, and decision curve analysis (DCA).Results: We identified 32 discriminative indicators (p < .05) between AHSP and AA. Five indicators, namely the lymphocyte ratio (LYMPH ratio), eosinophil ratio (EO ratio), eosinophil count (EO count), neutrophil ratio (NEUT ratio), and C‐reactive protein (CRP), exhibited strong performance in distinguishing AHSP from AA (AUC ≥ 0.80). Among the various prediction models, the XGBoost model displayed superior performance evidenced by the highest AUC (XGBoost = 0.895, other models < 0.89), accuracy (XGBoost = 0.824, other models < 0.81), and Kappa value (XGBoost = 0.621, other models < 0.60) in the validation set. After optimization, the XGBoost model demonstrated remarkable diagnostic performance for AHSP and AA (AUC > 0.95). Both the calibration curve and decision curve analysis suggested the promising clinical utility and net benefits of the XGBoost model.Conclusion: The AI‐based machine learning model exhibits high prediction accuracy and can differentiate AHSP and AA from a data‐driven perspective.
- 31 October 2023
- Published by Wiley in International Journal of Rheumatic Diseases
- Vol. 26 (12) , 2534-2542
Artificial intelligence differentiates abdominal Henoch‐Schönlein purpura from acute appendicitis in children
Objective: This study aims to construct an artificial intelligence (AI) model capable of effectively discriminating between abdominal Henoch‐Schönlein purpura (AHSP) and acute appendicitis (AA) in pediatric patients.Methods: A total of 6965 participants, comprising 2201 individuals with AHSP and 4764 patients with AA, were enrolled in the study. Additionally, 53 laboratory indicators were taken into consideration. Five distinct artificial intelligence (AI) models were developed employing machine learning algorithms, namely XGBoost, AdaBoost, Gaussian Naïve Bayes (GNB), MLPClassifier (MLP), and support vector machine (SVM). The performance of these prediction models was assessed through receiver operating characteristic (ROC) curve analysis, calibration curve assessment, and decision curve analysis (DCA).Results: We identified 32 discriminative indicators (p < .05) between AHSP and AA. Five indicators, namely the lymphocyte ratio (LYMPH ratio), eosinophil ratio (EO ratio), eosinophil count (EO count), neutrophil ratio (NEUT ratio), and C‐reactive protein (CRP), exhibited strong performance in distinguishing AHSP from AA (AUC ≥ 0.80). Among the various prediction models, the XGBoost model displayed superior performance evidenced by the highest AUC (XGBoost = 0.895, other models < 0.89), accuracy (XGBoost = 0.824, other models < 0.81), and Kappa value (XGBoost = 0.621, other models < 0.60) in the validation set. After optimization, the XGBoost model demonstrated remarkable diagnostic performance for AHSP and AA (AUC > 0.95). Both the calibration curve and decision curve analysis suggested the promising clinical utility and net benefits of the XGBoost model.Conclusion: The AI‐based machine learning model exhibits high prediction accuracy and can differentiate AHSP and AA from a data‐driven perspective.
- RetractedOpen Access
- 30 August 2021
- Published by Wiley in Disease Markers
- Vol. 2021, 1-9
Development and Validation of Diagnostic Models for Hand-Foot-and-Mouth Disease in Children
Objective. To find risk markers and develop new clinical predictive models for the differential diagnosis of hand-foot-and-mouth disease (HFMD) with varying degrees of disease. Methods. 19766 children with HFMD and 64 clinical indexes were included in this study. The patients included in this study were divided into the mild patients’ group (mild) with 12292 cases, severe patients’ group (severe) with 6508 cases, and severe patients with respiratory failure group (severe-RF) with 966 cases. Single-factor analysis was carried out on 64 indexes collected from patients when they were admitted to the hospital, and the indexes with statistical differences were selected as the prediction factors. Binary multivariate logistic regression analysis was used to construct the prediction models and calculate the adjusted odds ratio (OR). Results. SP, DP, NEUT#, NEUT%, RDW-SD, RDW-CV, GGT, CK/CK-MB, and Glu were risk markers in mild/severe, mild/severe-RF, and severe/severe-RF. Glu was a diagnostic marker for mild/severe-RF ( , 95% CI: 0.78-0.82); the predictive model constructed by temperature, SP, MOMO%, EO%, RDW-SD, GLB, CRP, Glu, BUN, and Cl could be used for the differential diagnosis of mild/severe ( ); the predictive model constructed by SP, age, NEUT#, PCT, TBIL, GGT, Mb, β2MG, Glu, and Ca could be used for the differential diagnosis of severe/severe-RF ( ). Conclusion. By analyzing clinical indicators, we have found the risk markers of HFMD and established suitable predictive models.
- 30 August 2021
- Published by Wiley in Disease Markers
- Vol. 2021, 1-9
RetractedOpen AccessDevelopment and Validation of Diagnostic Models for Hand-Foot-and-Mouth Disease in Children
Objective. To find risk markers and develop new clinical predictive models for the differential diagnosis of hand-foot-and-mouth disease (HFMD) with varying degrees of disease. Methods. 19766 children with HFMD and 64 clinical indexes were included in this study. The patients included in this study were divided into the mild patients’ group (mild) with 12292 cases, severe patients’ group (severe) with 6508 cases, and severe patients with respiratory failure group (severe-RF) with 966 cases. Single-factor analysis was carried out on 64 indexes collected from patients when they were admitted to the hospital, and the indexes with statistical differences were selected as the prediction factors. Binary multivariate logistic regression analysis was used to construct the prediction models and calculate the adjusted odds ratio (OR). Results. SP, DP, NEUT#, NEUT%, RDW-SD, RDW-CV, GGT, CK/CK-MB, and Glu were risk markers in mild/severe, mild/severe-RF, and severe/severe-RF. Glu was a diagnostic marker for mild/severe-RF ( , 95% CI: 0.78-0.82); the predictive model constructed by temperature, SP, MOMO%, EO%, RDW-SD, GLB, CRP, Glu, BUN, and Cl could be used for the differential diagnosis of mild/severe ( ); the predictive model constructed by SP, age, NEUT#, PCT, TBIL, GGT, Mb, β2MG, Glu, and Ca could be used for the differential diagnosis of severe/severe-RF ( ). Conclusion. By analyzing clinical indicators, we have found the risk markers of HFMD and established suitable predictive models.
- 1 December 2020
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 55 (12) , 2766-2771
Analysis of the predictors of surgical treatment and intestinal necrosis in children with intestinal obstruction
- 1 December 2020
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 55 (12) , 2766-2771
Analysis of the predictors of surgical treatment and intestinal necrosis in children with intestinal obstruction